BlackRock
NVNO

BlackRock’s enVVeno Medical NVNO Stock Holding History

BlackRock’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.6K Buy
1,840
+112
+6% +$1.23K ﹤0.01% 5316
2025
Q4 		$19.4K Buy
1,728
+18
+1% +$350 ﹤0.01% 5224
2025
Q3 		$54.2K Buy
1,710
+70
+4% +$7.15K ﹤0.01% 4968
2025
Q2 		$229K Buy
1,640
+493
+43% +$58.3K ﹤0.01% 4634
2025
Q1 		$106K Sell
1,147
-14
-1% -$1.56K ﹤0.01% 4756
2024
Q4 		$123K Buy
1,161
+5
+0.4% +$559 ﹤0.01% 4739
2024
Q3 		$136K Buy
1,156
+28
+2% +$5.14K ﹤0.01% 4612
2024
Q2 		$207K Buy
1,128
+57
+5% +$9.95K ﹤0.01% 4541
2024
Q1 		$204K Sell
1,071
-19
-2% -$3.41K ﹤0.01% 4573
2023
Q4 		$196K Buy
1,090
+202
+23% +$32.2K ﹤0.01% 4643
2023
Q3 		$168K Sell
888
-75
-8% -$12.5K ﹤0.01% 4725
2023
Q2 		$104K Sell
963
-21
-2% -$2.73K ﹤0.01% 4897
2023
Q1 		$161K Buy
984
+18
+2% +$3.36K ﹤0.01% 4833
2022
Q4 		$172K Buy
966
+4
+0.4% +$813 ﹤0.01% 4891
2022
Q3 		$211K Buy
962
+7
+0.7% +$1.49K ﹤0.01% 4962
2022
Q2 		$127K Sell
955
-143
-13% -$22.2K ﹤0.01% 5166
2022
Q1 		$244K Buy
1,098
+30
+3% +$5.82K ﹤0.01% 5058
2021
Q4 		$246K Buy
1,068
+521
+95% +$147K ﹤0.01% 5062
2021
Q3 		$199K Sell
547
-94
-15% -$24.3K ﹤0.01% 4991
2021
Q2 		$154K Buy
+641
New +$138K ﹤0.01% 4953

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock's NVNO Position: Q1 2026 in Review

BlackRock increased its enVVeno Medical (NVNO) stake by 6.5% in Q1 2026, buying an estimated $1.23K and bringing the position to 1,840 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5316.

BlackRock first reported a position in NVNO in Q2 2021 and has held it in 20 quarters since. The position peaked at $246K in Q4 2021. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • BlackRock held 1,840 shares of enVVeno Medical worth $18.6K as of Q1 2026.
  • BlackRock bought 112 enVVeno Medical shares in Q1 2026, an estimated $1.23K.
  • enVVeno Medical made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5316 holding.
  • BlackRock first reported a position in enVVeno Medical in Q2 2021 and has held it in 20 quarters since.
  • BlackRock's enVVeno Medical position peaked at $246K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.